| |
Revolutionize your clinical trial! IQVIA experts discuss how the synergy between wearables and eCOA will enhance data collection, patient engagement, regulatory compliance and streamline trial processes. Watch this webinar replay now.
|
|
Today’s Big NewsJul 16, 2025 |
| By James Waldron AstraZeneca’s plans to get an amyloidosis blockbuster drug to market look further out of reach after the pharma’s anti-fibril antibody failed to reduce deaths and hospitalizations in a phase 3 study. |
|
|
|
By Fraiser Kansteiner With GSK kicking its R&D engine into high gear in recent years, a shuffling of the scientific priorities at the company is only natural. But for a small subset of staffers, that redistribution of resources will mean job cuts, even as GSK eyes major R&D investments on the horizon. |
By Nick Paul Taylor The National Institutes of Health has fired its chief operating officer amid a probe into whether his wife could have benefited from a $3.3 million contract, according to The Washington Post. |
Sponsored by Evernorth Specialty Services Choosing the right specialty pharmacy partner is critical. Especially when you’re treating rare, chronic and complex conditions. You need a partner who delivers more than just logistics management, therapy fulfillment and generalized patient care. |
|
Overcome biotherapeutic protein expression challenges with advanced vector technology for a range of multi-gene and difficult to express proteins. Watch the presentation to learn more.
|
|
By Darren Incorvaia The Department of Health and Human Services (HHS) is laying off certain employees who were notified months ago of the reduction in force (RIF) after the Supreme Court lifted a district court order blocking the layoffs, an agency spokesperson confirmed to Fierce Biotech. |
By James Waldron Seven months after pressing pause on its plans for its PKMYT1 inhibitor, Repare Therapeutics has found a partner to take the cancer drug forward. |
By Gabrielle Masson Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor known as glioblastoma. |
By James Waldron The FDA has lifted one of the two clinical holds placed on Kezar Life Sciences’ zetomipzomib, leading the biotech to speculate on whether to reignite another program for the same drug that remains under hold. |
By Darren Incorvaia A pair of CROs from opposite sides of the Atlantic Ocean are merging to form a global organization. Evestia Clinical and Atlantic Research Group are joining forces to bring clients expertise in oncology, immunology, neurology and late-stage clinical trials, according to a July 15 release. |
By Andrea Park Fittingly enough, for its third acquisition in as many years, Deerfield Group has picked up Triple Threat Communications. |
By Darius Tahir, Kaiser Health News Researchers say they fear the VA's Million Veteran Program is in limbo, jeopardizing years of work in gathering genetic data, surveys and blood samples. |
By Dave Muoio Of the $6.5 billion tally of ineligible rebate funds, $4.2 billion of missed managed care plan rebates is borne by the federal government and $2.3 billion is shouldered by state governments. |
Fierce podcastsDon’t miss an episode |
| | Biopharma layoffs have held steady through mid-2025, and in this episode of "The Top Line," we dig into the numbers, closures and policy changes shaping the trend. |
|
|---|
|
|
| WhitepaperThis white paper outlines how we apply industry-backed practices and proprietary technologies to proactively safeguard sterility and performance. Sponsored by: Lonza |
| WhitepaperPresented by Blue Matter, strategic consultants in the life sciences Sponsored by Blue Matter Consulting |
| Executive SummaryBiotech innovation doesn’t slow down—and neither should your lab partner. This brief outlines how early scientific engagement, operational transparency, and integrated global lab services help reduce risk, stay on schedule, and deliver results. Whether you're navigating your first trial or scaling a growing pipeline, see how a purpose-built lab model can help you move smarter and faster. Sponsored by: IQVIA Laboratories |
| |
|
